30ACTIVITIES
1ORGS REPRESENTED
41BILLS
Organizations represented
1Orgs whose LD-2 filings list Sylvia as an active lobbyist, sorted by activity volume.
Bills they file on
41S. 65214 mentions
S. 83214 mentions
S. 89114 mentions
S. 93214 mentions
H.R. 94614 mentions
H.R. 126214 mentions
H.R. 149214 mentions
H.R. 221414 mentions
S. 35513 mentions
S. 141413 mentions
S. 195413 mentions
S. 86412 mentions
S. 229612 mentions
S. 265812 mentions
H.R. 431712 mentions
+ 26 more bills referenced in their activities
Topics in Filings
67Policy topics Sylvia files on across all their LD-2 activities.
Inflation Reduction Act×28
Drug cost and pricing policy×28
One Big Beautiful Bill Act×28
Modernizing and Ensuring PBM Accountability×14
Accountability, and Integrity Now and for the Future×14
Show all 67 topics (+62 more) ▾
Vaccine policy×14
Pharmacy Benefit Manager reform×14
Drug importation policy×14
FDA policy×14
Orphan Drug Act×14
Compounding policy×14
Supply chain policy×14
Clinical trial policy×14
Issues 340B drug discount program policy×14
Biosimilar approval and reimbursement policy×14
Artificial intelligence policy×14
Part D redesign and policy×14
Part B policy×14
Medicare rebate policy×14
Center for Medicare and Medicaid Innovation×14
Medicaid rebate policy×14
FDA Modernization×14
Biosimilar Red Tape Elimination Act×13
Bipartisan Health Care Act×12
BIOSECURE Act×12
IRA price negotiation expansion policy×12
Most Favored Nation×12
MAHA Commission Report×12
Make Our Children Healthy Again Competition policy×12
Issues 340B rebate pilot program Patient assistance program policy×12
Biosimilars Access and Affordability Act×12
PBM Price Transparency and Accountability Act×11
Mikaela Naylon Give Kids a Chance Act×11
PBM Reform×11
HELP Copays Act×11
Antimicrobial resistance policy×11
GENErating cost Reductions for U.S×11
Medicare Against Rising Drugs Costs×11
CLEAR LABELS Act×10
Most Favored Patients Act×10
FAIR ACT×10
SECURE Rx Act×10
User fee issues×4
Rural Development×4
Give Kids a Chance Act×3
Antimicrobial resistance×3
Science, and Related Agencies Appropriations Act, 2026×3
Accelerated approval policy×2
Competition policy×2
Patient assistance program policy×2
Drug shortages policy×2
Insulin policy×2
Medicaid waiver policy×2
Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H×2
Res. 566: Providing for consideration of the Senate amendment to the bill×2
Protecting Patients from Deceptive Drug Ads Act×1
Innovation in Pediatric Drugs Act×1
Pandemic preparedness policy×1
Saving Seniors Money on Prescriptions Act×1
Military Construction×1
Expedited Acccess to Biosimilars Act×1
MAPS Act×1
Medication Affordability and Patent Integrity Act×1
Orphan Cures Act×1
Prescription Information Modernization×1
MVP Act×1
Open Payments Expansion Act×1
Pulled from the org’s own LD-2 disclosures. See the source filings ↓
Issue mix
LDA general-issue codes weighted by activity count.
Health Issues14
Medicare/Medicaid14
Budget/Appropriations2